BioLife Solutions to Participate in Upcoming Investor Conferences in May and June 2025

About this update from Biolife Solutions, Inc.

BOTHELL, Wash. , May 14, 2025 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS ), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the company will be participating in the following investor conferences: 22nd Annual Craig-Hallum Institutional Investor Conference May 28, 2025 Minneapolis, MN at the Renaissance Hotel Benchmark 2025 Healthcare House Call Virtual Conference May 29, 2025 Virtual Jefferies Global Life Sciences Conference June 3 – 5, 2025 New York, NY at the Marriott Marquis Wolfe Research Small & Mid-Cap Conference June 5, 2025 New York, NY at Wolfe Headquarters Northland Growth Conference 2025 June 25, 2025 Virtual About BioLife Solutions BioLife Solutions is a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) and broader biopharma markets. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution. For more information, please visit www.biolifesolutions.com or follow BioLife on LinkedIn and X . Media & Investor Relations At the CompanyTroy Wichterman Chief Financial Officer(425) 402-1400 [email protected] InvestorsAlliance Advisors IR Jody Cain (310) 691-7100 [email protected] View original content to download multimedia: https://www.prnewswire.com/news-releases/biolife-solutions-to-participate-in-upcoming-investor-conferences-in-may-and-june-2025-302454438.html SOURCE BioLife Solutions, Inc.

View stock analysis, news, and events for Biolife Solutions, Inc.